Dynamic Local Average Treatment Effects

Read original: arXiv:2405.01463 - Published 5/15/2024 by Ravi B. Sojitra, Vasilis Syrgkanis

🎯

Overview

The paper considers Dynamic Treatment Regimes (DTRs) with one-sided non-compliance, which arise in applications like digital recommendations and adaptive medical trials.
In these settings, decision-makers encourage individuals to take treatments over time, adapting encouragements based on previous encouragements, treatments, states, and outcomes.
Individuals may choose to (not) comply with a treatment recommendation based on unobserved confounding factors.
The paper provides non-parametric identification, estimation, and inference for Dynamic Local Average Treatment Effects, which are expected values of multi-period treatment contrasts among appropriately defined complier subpopulations.

Plain English Explanation

The paper looks at situations where decision-makers, like digital platforms or medical researchers, try to encourage people to take certain actions over time, but the people may or may not actually follow the recommendations. This can happen for reasons that the decision-makers can't observe or measure.

For example, a digital platform might recommend different products to users over time, based on their past behavior and the platform's goals. But users can choose whether or not to actually buy the recommended products. Or in a medical study, researchers might try different treatments on patients over time, but the patients can decide whether to follow the treatment recommendations or not.

The paper shows how to identify, estimate, and draw conclusions about the average effects of these kinds of multi-step treatment recommendations, even when some people don't follow the recommendations. This allows decision-makers to better understand the impacts of their recommendations, even when there is "non-compliance" by the people receiving them.

The key ideas are to focus on the local average effects - that is, the average effects among the people who would actually comply with the recommendations if they were offered. And the paper shows how to do this in a non-parametric way, without making strong assumptions about the underlying models or distributions.

The paper also discusses some special cases, like "Staggered Adoption" and "Staggered Compliance" settings, where additional assumptions allow identifying the effects of treatment recommendations over multiple time periods.

Technical Explanation

The paper considers Dynamic Treatment Regimes (DTRs) in settings with one-sided non-compliance. This means that decision-makers encourage individuals to take treatments over time, adapting their encouragements based on previous encouragements, treatments, states, and outcomes. However, individuals may choose to (not) comply with a treatment recommendation based on unobserved confounding factors.

The authors provide non-parametric identification, estimation, and inference for Dynamic Local Average Treatment Effects (DLATEs). DLATEs are expected values of multi-period treatment contrasts among appropriately defined complier subpopulations. Under standard assumptions from the Instrumental Variable and DTR literature, the authors show that one can identify local average effects of contrasts that correspond to offering treatment at any single time step.

Furthermore, under an additional cross-period effect-compliance independence assumption, which holds in Staggered Adoption settings and a generalization called Staggered Compliance settings, the authors identify local average treatment effects of treating in multiple time periods.

This allows for a more nuanced understanding of the impacts of multi-step treatment recommendations, even when there is non-compliance by the individuals receiving the recommendations. The non-parametric approach avoids strong assumptions about the underlying models or distributions.

Critical Analysis

The paper provides a robust framework for analyzing dynamic treatment regimes with non-compliance, which is an important and common challenge in areas like digital recommendations and adaptive clinical trials.

One potential limitation is the reliance on the cross-period effect-compliance independence assumption to identify local average treatment effects over multiple time periods. This assumption may not hold in all real-world settings, and the authors acknowledge that further research is needed to relax or validate this assumption.

Additionally, the paper focuses on identifying and estimating local average treatment effects, which may not fully capture the population-level impacts of the treatment regimes. Further work could explore methods for extrapolating the local effects to the broader population, or for jointly modeling compliance and treatment effects.

Overall, this research represents an important contribution to the literature on causal inference and dynamic treatment regimes. The non-parametric approach and consideration of non-compliance are valuable advancements that can help improve the reliability and applicability of decision-making in a variety of domains.

Conclusion

This paper presents a novel framework for analyzing Dynamic Treatment Regimes (DTRs) with one-sided non-compliance, a common challenge in applications like digital recommendations and adaptive medical trials. The authors provide non-parametric identification, estimation, and inference for Dynamic Local Average Treatment Effects (DLATEs), which capture the average effects of multi-step treatment recommendations among individuals who would comply with the recommendations if offered.

The paper's technical contributions, including the analysis of Staggered Adoption and Staggered Compliance settings, represent important advancements in causal inference and decision-making under uncertainty. This research can help decision-makers in a variety of domains better understand the impacts of their interventions, even when some individuals do not fully comply with the recommended actions.

While the paper has some limitations, such as the reliance on the cross-period effect-compliance independence assumption, it lays the groundwork for further developments in this area. Continued research in this direction can lead to more reliable and impactful decision-making, with potential benefits across industries and applications.

This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

🎯

Dynamic Local Average Treatment Effects

Ravi B. Sojitra, Vasilis Syrgkanis

We consider Dynamic Treatment Regimes (DTRs) with One Sided Noncompliance that arise in applications such as digital recommendations and adaptive medical trials. These are settings where decision makers encourage individuals to take treatments over time, but adapt encouragements based on previous encouragements, treatments, states, and outcomes. Importantly, individuals may not comply with encouragements based on unobserved confounders. For settings with binary treatments and encouragements, we provide nonparametric identification, estimation, and inference for Dynamic Local Average Treatment Effects (LATEs), which are expected values of multiple time period treatment contrasts for the respective complier subpopulations. Under standard assumptions in the Instrumental Variable and DTR literature, we show that one can identify Dynamic LATEs that correspond to treating at single time steps. Under an additional cross-period effect-compliance independence assumption, which is satisfied in Staggered Adoption settings and a generalization of them, which we define as Staggered Compliance settings, we identify Dynamic LATEs for treating in multiple time periods.

5/15/2024

Experimenting on Markov Decision Processes with Local Treatments

Shuze Chen, David Simchi-Levi, Chonghuan Wang

As service systems grow increasingly complex and dynamic, many interventions become localized, available and taking effect only in specific states. This paper investigates experiments with local treatments on a widely-used class of dynamic models, Markov Decision Processes (MDPs). Particularly, we focus on utilizing the local structure to improve the inference efficiency of the average treatment effect. We begin by demonstrating the efficiency of classical inference methods, including model-based estimation and temporal difference learning under a fixed policy, as well as classical A/B testing with general treatments. We then introduce a variance reduction technique that exploits the local treatment structure by sharing information for states unaffected by the treatment policy. Our new estimator effectively overcomes the variance lower bound for general treatments while matching the more stringent lower bound incorporating the local treatment structure. Furthermore, our estimator can optimally achieve a linear reduction with the number of test arms for a major part of the variance. Finally, we explore scenarios with perfect knowledge of the control arm and design estimators that further improve inference efficiency.

7/30/2024

Reinforcement Learning in Dynamic Treatment Regimes Needs Critical Reexamination

Zhiyao Luo, Yangchen Pan, Peter Watkinson, Tingting Zhu

In the rapidly changing healthcare landscape, the implementation of offline reinforcement learning (RL) in dynamic treatment regimes (DTRs) presents a mix of unprecedented opportunities and challenges. This position paper offers a critical examination of the current status of offline RL in the context of DTRs. We argue for a reassessment of applying RL in DTRs, citing concerns such as inconsistent and potentially inconclusive evaluation metrics, the absence of naive and supervised learning baselines, and the diverse choice of RL formulation in existing research. Through a case study with more than 17,000 evaluation experiments using a publicly available Sepsis dataset, we demonstrate that the performance of RL algorithms can significantly vary with changes in evaluation metrics and Markov Decision Process (MDP) formulations. Surprisingly, it is observed that in some instances, RL algorithms can be surpassed by random baselines subjected to policy evaluation methods and reward design. This calls for more careful policy evaluation and algorithm development in future DTR works. Additionally, we discussed potential enhancements toward more reliable development of RL-based dynamic treatment regimes and invited further discussion within the community. Code is available at https://github.com/GilesLuo/ReassessDTR.

6/5/2024

DTR-Bench: An in silico Environment and Benchmark Platform for Reinforcement Learning Based Dynamic Treatment Regime

Zhiyao Luo, Mingcheng Zhu, Fenglin Liu, Jiali Li, Yangchen Pan, Jiandong Zhou, Tingting Zhu

Reinforcement learning (RL) has garnered increasing recognition for its potential to optimise dynamic treatment regimes (DTRs) in personalised medicine, particularly for drug dosage prescriptions and medication recommendations. However, a significant challenge persists: the absence of a unified framework for simulating diverse healthcare scenarios and a comprehensive analysis to benchmark the effectiveness of RL algorithms within these contexts. To address this gap, we introduce textit{DTR-Bench}, a benchmarking platform comprising four distinct simulation environments tailored to common DTR applications, including cancer chemotherapy, radiotherapy, glucose management in diabetes, and sepsis treatment. We evaluate various state-of-the-art RL algorithms across these settings, particularly highlighting their performance amidst real-world challenges such as pharmacokinetic/pharmacodynamic (PK/PD) variability, noise, and missing data. Our experiments reveal varying degrees of performance degradation among RL algorithms in the presence of noise and patient variability, with some algorithms failing to converge. Additionally, we observe that using temporal observation representations does not consistently lead to improved performance in DTR settings. Our findings underscore the necessity of developing robust, adaptive RL algorithms capable of effectively managing these complexities to enhance patient-specific healthcare. We have open-sourced our benchmark and code at https://github.com/GilesLuo/DTR-Bench.

5/30/2024